These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. LIGHTSITE III: 13-Month Efficacy and Safety Evaluation of Multiwavelength Photobiomodulation in Nonexudative (Dry) Age-Related Macular Degeneration Using the Lumithera Valeda Light Delivery System. Boyer D; Hu A; Warrow D; Xavier S; Gonzalez V; Lad E; Rosen RB; Do D; Schneiderman T; Ho A; Munk MR; Jaffe G; Tedford SE; Croissant CL; Walker M; Rückert R; Tedford CE Retina; 2024 Mar; 44(3):487-497. PubMed ID: 37972955 [TBL] [Abstract][Full Text] [Related]
3. Racial differences in age-related macular degeneration rates in the United States: a longitudinal analysis of a managed care network. Vanderbeek BL; Zacks DN; Talwar N; Nan B; Musch DC; Stein JD Am J Ophthalmol; 2011 Aug; 152(2):273-282.e3. PubMed ID: 21696700 [TBL] [Abstract][Full Text] [Related]
5. Growth of nonexudative macular neovascularization in age-related macular degeneration: an indicator of biological lesion activity. Wang Y; Sun J; Wu J; Jia H; Feng J; Chen J; Yan Q; Huang P; Wang F; Bo Q; Sun X Eye (Lond); 2023 Jul; 37(10):2048-2054. PubMed ID: 36434285 [TBL] [Abstract][Full Text] [Related]
6. Emerging Therapies in Nonexudative Age-Related Macular Degeneration in 2020. Samanta A; Aziz AA; Jhingan M; Singh SR; Khanani AM; Chhablani J Asia Pac J Ophthalmol (Phila); 2021 Jan; 10(4):408-416. PubMed ID: 33512911 [TBL] [Abstract][Full Text] [Related]